Author: Dr. David Lowemann

FDA Approves New Urinary Infection Treatment

The U.S. Food and Drug Administration has approved Iterum Therapeutics’ oral antibiotic to treat certain types of bacterial urinary tract infections (UTI) in adult women, the health regulator said on Friday. The drug, Orlynvah, has been approved to treat uncomplicated UTIs… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]

Published on October 25, 2024

Studying Wikipedia browsing habits to learn how people learn

A collaborative team of researchers led by Dale Zhou, who did his Ph.D. at the University of Pennsylvania’s Perelman School of Medicine, and Dani Bassett in Penn’s School of Engineering and Applied Science looked at how nearly half a million people around the world use Wikipedia’s knowledge networks. They found stark differences in browsing habits […]

Published on October 25, 2024

Skeletal muscle health amid growing use of weight loss medications

A recent article highlights the critical importance of skeletal muscle mass in the context of medically induced weight loss, particularly with the widespread use of GLP-1 receptor agonists. These medications, celebrated for their effectiveness in treating obesity, have raised concerns regarding the potential for substantial muscle loss as part of the weight loss process. Read […]

Published on October 25, 2024